RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yohannes Tesfaigzi to Interleukin-13

This is a "connection" page, showing publications Yohannes Tesfaigzi has written about Interleukin-13.
Connection Strength

1.657
  1. Chand HS, Harris JF, Tesfaigzi Y. IL-13 in LPS-Induced Inflammation Causes Bcl-2 Expression to Sustain Hyperplastic Mucous cells. Sci Rep. 2018 01 11; 8(1):436.
    View in: PubMed
    Score: 0.640
  2. Chand HS, Mebratu YA, Kuehl PJ, Tesfaigzi Y. Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner. J Allergy Clin Immunol. 2017 11; 140(5):1456-1459.e9.
    View in: PubMed
    Score: 0.621
  3. Xiang J, Rir-Sim-Ah J, Tesfaigzi Y. IL-9 and IL-13 induce mucous cell metaplasia that is reduced by IFN-gamma in a Bax-mediated pathway. Am J Respir Cell Mol Biol. 2008 Mar; 38(3):310-7.
    View in: PubMed
    Score: 0.314
  4. Schwalm K, Stevens JF, Jiang Z, Schuyler MR, Schrader R, Randell SH, Green FH, Tesfaigzi Y. Expression of the proapoptotic protein Bax is reduced in bronchial mucous cells of asthmatic subjects. Am J Physiol Lung Cell Mol Physiol. 2008 Jun; 294(6):L1102-9.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support